BIODESIX INC (BDSX) Stock Analyst Ratings
USA - NASDAQ:BDSX - US09075X1081 - Common Stock
7.73 USD
-0.06 (-0.77%)
7.42 USD
-0.31 (-4.01%)
ChartMill assigns a Buy % Consensus number of 80% to BDSX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.7. This target is 361.84% above the current price.
BDSX was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BDSX.
In the previous month the buy percentage consensus was at a similar level.
BDSX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-21 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-14 | Lake Street | Maintains | Buy -> Buy |
| 2025-05-14 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-04-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-07-26 | Craig-Hallum | Initiate | Buy |
| 2024-05-13 | TD Cowen | Initiate | Buy |
| 2024-05-03 | Lake Street | Initiate | Buy |
| 2024-03-04 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2022-05-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-20 | Cowen & Co. | Initiate | Outperform |
| 2021-11-17 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-05-12 | Morgan Stanley | Maintains | Overweight |
| 2021-03-18 | Morgan Stanley | Maintains | Overweight |
BIODESIX INC / BDSX FAQ
Can you provide the average price target for BIODESIX INC stock?
11 analysts have analysed BDSX and the average price target is 35.7 USD. This implies a price increase of 361.84% is expected in the next year compared to the current price of 7.73.
How do analysts rate BIODESIX INC (BDSX)?
The consensus rating for BIODESIX INC (BDSX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BDSX stock?
The number of analysts covering BIODESIX INC (BDSX) is 11.